POINT Biopharma Global Inc - ESG Rating & Company Profile powered by AI
The analysis of POINT Biopharma Global Inc employs data points from across the web and also from available documents by POINT Biopharma Global Inc. Browse to the bottom of this page for potential risks for POINT Biopharma Global Inc based on industry, geography and size. The webpage is a free E,S&G report covering POINT Biopharma Global Inc.
POINT Biopharma Global Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.4; made up of an environmental score of 3.2, social score of 4.8 and governance score of 5.3.
4.4
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 1252 | Wntresearch AB | 4.5 | High |
| 1252 | Verano Holdings Corp | 4.5 | High |
| 1284 | POINT Biopharma Global Inc | 4.4 | High |
| 1284 | Adinath Biolabs Ltd | 4.4 | High |
| 1284 | Aligos Therapeutics Inc | 4.4 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does POINT Biopharma Global Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes POINT Biopharma Global Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes POINT Biopharma Global Inc report the average age of the workforce?
Sign up for free to unlockDoes POINT Biopharma Global Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes POINT Biopharma Global Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes POINT Biopharma Global Inc disclose cybersecurity risks?
Sign up for free to unlockDoes POINT Biopharma Global Inc offer flexible work?
Sign up for free to unlockDoes POINT Biopharma Global Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes POINT Biopharma Global Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes POINT Biopharma Global Inc conduct supply chain audits?
Sign up for free to unlockDoes POINT Biopharma Global Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes POINT Biopharma Global Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes POINT Biopharma Global Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes POINT Biopharma Global Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes POINT Biopharma Global Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes POINT Biopharma Global Inc disclose water use targets?
Sign up for free to unlockDoes POINT Biopharma Global Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid POINT Biopharma Global Inc have a product recall in the last two years?
Sign up for free to unlockDoes POINT Biopharma Global Inc disclose incidents of discrimination?
Sign up for free to unlockDoes POINT Biopharma Global Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas POINT Biopharma Global Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes POINT Biopharma Global Inc disclose parental leave metrics?
Sign up for free to unlockDoes POINT Biopharma Global Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes POINT Biopharma Global Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes POINT Biopharma Global Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes POINT Biopharma Global Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes POINT Biopharma Global Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes POINT Biopharma Global Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs POINT Biopharma Global Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes POINT Biopharma Global Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes POINT Biopharma Global Inc disclose its waste policy?
Sign up for free to unlockDoes POINT Biopharma Global Inc report according to TCFD requirements?
Sign up for free to unlockDoes POINT Biopharma Global Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes POINT Biopharma Global Inc disclose energy use targets?
Sign up for free to unlockDoes POINT Biopharma Global Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes POINT Biopharma Global Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for POINT Biopharma Global Inc
These potential risks are based on the size, segment and geographies of the company.
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate cancer; and PNT2003, a somatostatin-targeted radioligand, which is in Phase III trial for the treatment of neuroendocrine tumors. The company is also developing PNT2001, a next-generation PSMA-targeting product candidate for the treatment of non-metastatic castration sensitive prostate cancer, which is under preclinical studies; and PNT-2004, a fibroblast activation protein-a targeting program being developed for use in multiple tumor types that is under preclinical studies. In addition, it has product candidates being developed on CanSEEK technology sub-licensed from both Bach Biosciences LLC and Avacta Life Sciences Limited. POINT Biopharma Global Inc. was founded in 2019 and is headquartered in Indianapolis, Indiana.